<div id="readability-page-1"><p>Quantinno Capital Management LP increased its stake in shares of  Medtronic PLC (NYSE:MDT - Free Report) by 42.1% in the 2nd quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The fund owned 417,488 shares of the medical technology company's stock after purchasing an additional 123,691 shares during the period. Quantinno Capital Management LP's holdings in Medtronic were worth $36,392,000 as of its most recent filing with the Securities &amp; Exchange Commission.</p><ul><li>Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum</li></ul><p>Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC lifted its position in shares of  Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock valued at $3,194,000 after acquiring an additional 37,265 shares in the last quarter.  Rathbones Group PLC boosted its stake in  Medtronic by 43.6% during the 1st quarter. Rathbones Group PLC now owns 8,131 shares of the medical technology company's stock worth $731,000 after purchasing an additional 2,468 shares during the last quarter.  Vestmark Advisory Solutions Inc. grew its holdings in shares of  Medtronic by 98.4% during the first quarter. Vestmark Advisory Solutions Inc. now owns 8,746 shares of the medical technology company's stock worth $786,000 after buying an additional 4,338 shares in the last quarter.  Kovitz Investment Group Partners LLC raised its position in shares of  Medtronic by 43.8% in the first quarter. Kovitz Investment Group Partners LLC now owns 108,030 shares of the medical technology company's stock valued at $9,708,000 after buying an additional 32,907 shares during the last quarter.  Finally, Inspire Trust Co. N.A. lifted its stake in  Medtronic by 4.5% in the 1st quarter. Inspire Trust Co. N.A. now owns 46,000 shares of the medical technology company's stock worth $4,134,000 after purchasing an additional 2,000 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Wall Street Analyst Weigh In</h2><p>Several research firms recently issued reports on MDT. JPMorgan Chase &amp; Co. raised their price objective on shares of Medtronic from $90.00 to $100.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, November 13th. Sanford C. Bernstein  set a $111.00 price target on shares of Medtronic in a report on Wednesday, November 19th. Wells Fargo &amp; Company lifted their price target on shares of Medtronic from $100.00 to $114.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 19th. Robert W. Baird increased their price objective on Medtronic from $103.00 to $109.00 and gave the stock a &#34;neutral&#34; rating in a research report on Wednesday, November 19th. Finally, UBS Group lifted their target price on Medtronic from $95.00 to $102.00 and gave the company a &#34;neutral&#34; rating in a research report on Wednesday, November 19th. One analyst  has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and twelve have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company  has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $110.44.</p><ul><li>MarketBeat Week in Review – 08/18 - 08/22</li></ul><p><b>View Our Latest Stock Report on MDT</b></p><h2>Medtronic Trading Down 1.0%</h2><p>Shares of NYSE MDT opened at $99.77 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.80 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $127.91 billion, a PE ratio of 26.89, a PEG ratio of 2.65 and a beta of 0.71. Medtronic PLC has a twelve month low of $79.29 and a twelve month high of $106.33. The stock has a fifty day simple moving average of $97.23 and a 200-day simple moving average of $92.66. </p><ul><li>Medtronic: The Opportunity Gets Healthier for Income Investors</li></ul><p>Medtronic (NYSE:MDT - Get Free Report) last announced its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 EPS for the quarter, beating analysts' consensus estimates of $1.31 by $0.05. The company had revenue of $8.96 billion during the quarter, compared to analysts' expectations of $8.86 billion. Medtronic had a return on equity of 14.86% and a net margin of 13.71%.Medtronic's revenue for the quarter was up 6.6% on a year-over-year basis. During the same period last year, the business posted $1.26 EPS. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS.  On average, equities analysts forecast that  Medtronic PLC will post 5.46 earnings per share for the current year. </p><h2>Medtronic Dividend Announcement</h2><p>The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Friday, December 26th will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, December 26th. Medtronic's dividend payout ratio  is presently 76.55%. </p><h2>About Medtronic</h2> (Free Report)<p>Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Medtronic</li><li>Procter &amp; Gamble <span>NYSE: PG<span></span></span> Pulls Back After Shaky Guidance</li><li>Dividend Powerhouses: 3 Blue-Chip Stocks Built for the Long Haul</li><li>3 Home Improvement Stocks that Can Upgrade Your Portfolio</li><li>3 Recently Downgraded Stocks to Avoid in 2026</li><li>What Are the FAANG Stocks and Are They Good Investments?</li><li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li></ul><p><strong>Want to see what other hedge funds are holding MDT?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1EVA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Medtronic Right Now?</h2><p>Before you consider Medtronic, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.</p><p>While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Quantinno Capital Management LP increased its stake in Medtronic PLC by 42.1% in Q2, owning 417,488 shares worth $36.39 million. Analysts have issued various ratings, with a consensus target price of $110.44. Medtronic's stock opened at $99.77, with a market cap of $127.91 billion. The company reported Q2 earnings of $1.36 per share, beating estimates.</p>

Medtronic PLC $MDT Shares Acquired by Quantinno Capital Management LP